Concepedia

Lewis Nasr

LN

11

Publications

360

Citations

10

H-Index

2023

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Albert Einstein College of Medicine

Augusta University Health

St. Jude Children's Research Hospital

Lewis Nasr is an author at The University of Texas MD Anderson Cancer Center specializing in public health, oncology, and social computing.

ORCID

Top concepts

Publications per year

2023–2024

11

Publications

11

Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory <i>FLT3</i>-Mutated AML

Nicholas J. Short, Naval Daver, Courtney D. DiNardo et al. · Journal of Clinical Oncology · 2024 · 120 citations · Full text

Results of the Simultaneous Combination of Ponatinib and Blinatumomab in Philadelphia Chromosome-Positive ALL

Hagop M. Kantarjian, Nicholas J. Short, Fadi Haddad et al. · Journal of Clinical Oncology · 2024 · 58 citations · Full text

A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents

Nicholas J. Short, Muharrem Müftüoğlu, Faustine Ong et al. · Journal of Hematology & Oncology · 2023 · 48 citations · Full text

A phase 1/2 study of mini-hyper-CVD plus venetoclax in patients with relapsed/refractory acute lymphoblastic leukemia

Nicholas J. Short, Elias Jabbour, Nitin Jain et al. · Blood Advances · 2024 · 28 citations · Full text

Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL

Yaqi Zhao, Nicholas J. Short, Hagop M. Kantarjian et al. · Blood · 2024 · 28 citations · Full text

Rows per page

1–5 of 11